HONUVITY
LIVE

Serial Number

97514093

Owner

Clementia Pharmaceuticals Inc.

Attorney

Makiko Coffland

Filing Date

Jul 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HONUVITY Trademark

Serial Number: 97514093

HONUVITY is a trademark filed by Clementia Pharmaceuticals Inc. on July 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Clementia Pharmaceuticals Inc.

1155 Rue Metcalfe, Suite 1500
Montreal, Quebec H3B2V6 , CA

Entity Type: 03

Trademark Details

Filing Date

July 21, 2022

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 19, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
May 14, 2026 EEXT
SOU EXTENSION 5 FILED
May 13, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 19, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 19, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 16, 2025 EX3G
SOU EXTENSION 3 FILED
May 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 28, 2025 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2025 AITU
SOU EXTENSION 2 FILED
Nov 15, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 16, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 16, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 19, 2023 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 26, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 26, 2023 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 15, 2023 GPRN
PRIORITY ACTION E-MAILED
May 15, 2023 GPRA
PRIORITY ACTION WRITTEN
May 15, 2023 CPRA
ASSIGNED TO EXAMINER
May 8, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2022 NWOS
NEW APPLICATION ENTERED
Jul 25, 2022 NWAP